<DOC>
	<DOCNO>NCT01138735</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy EpiduoÂ® ( adapalene benzoyl peroxide ) Gel 0.1 % /2.5 % administer daily 12 week subject 9 11 year age acne vulgaris .</brief_summary>
	<brief_title>Epiduo Pediatric Acne Study</brief_title>
	<detailed_description />
	<mesh_term>Adapalene , Benzoyl Peroxide Drug Combination</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Clinical diagnosis acne vulgaris facial involvement Score 3 ( moderate ) Investigator 's Global Assessment ( IGA ) scale A minimum 20 100 total lesion ( Noninflammatory and/or Inflammatory ) face ( include nose ) Baseline Acne nodule acne cyst Acne conglobata , acne fulminans , secondary acne ( chloracne , druginduced acne , etc . ) , severe acne require systemic treatment Underlying disease and/or dermatologic condition require use interfering topical systemic therapy might interfere study assessment Use prohibit medication prior study and/or unwilling refrain use study</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>